These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer. Gao Y; Zhu Y; Yuan Z Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495 [TBL] [Abstract][Full Text] [Related]
23. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer. Hayashi N; Yamauchi H Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809 [TBL] [Abstract][Full Text] [Related]
24. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704 [TBL] [Abstract][Full Text] [Related]
25. The emerging role of circulating tumor cell detection in genitourinary cancer. Small AC; Gong Y; Oh WK; Hall SJ; van Rijn CJ; Galsky MD J Urol; 2012 Jul; 188(1):21-6. PubMed ID: 22578722 [TBL] [Abstract][Full Text] [Related]
26. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Vona G; Estepa L; Béroud C; Damotte D; Capron F; Nalpas B; Mineur A; Franco D; Lacour B; Pol S; Bréchot C; Paterlini-Bréchot P Hepatology; 2004 Mar; 39(3):792-7. PubMed ID: 14999698 [TBL] [Abstract][Full Text] [Related]
27. Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies. Nadal R; Lorente JA; Rosell R; Serrano MJ Expert Rev Mol Diagn; 2013 Apr; 13(3):295-307. PubMed ID: 23570407 [TBL] [Abstract][Full Text] [Related]
28. Real-time liquid biopsy in cancer patients: fact or fiction? Pantel K; Alix-Panabières C Cancer Res; 2013 Nov; 73(21):6384-8. PubMed ID: 24145355 [TBL] [Abstract][Full Text] [Related]
29. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Budd GT Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis of circulating tumor cells in prostate cancer patients. Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900 [TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility. Ignatiadis M; Lee M; Jeffrey SS Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805 [TBL] [Abstract][Full Text] [Related]
32. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Riethdorf S; Pantel K Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002 [TBL] [Abstract][Full Text] [Related]
34. Biologic challenges in the detection of circulating tumor cells. Joosse SA; Pantel K Cancer Res; 2013 Jan; 73(1):8-11. PubMed ID: 23271724 [TBL] [Abstract][Full Text] [Related]
35. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells. Gazzaniga P; Raimondi C; Nicolazzo C; Carletti R; di Gioia C; Gradilone A; Cortesi E Expert Rev Mol Diagn; 2015; 15(7):925-32. PubMed ID: 25959553 [TBL] [Abstract][Full Text] [Related]
36. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance. Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323 [TBL] [Abstract][Full Text] [Related]
37. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790 [TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255 [TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis. Xie ZB; Yao L; Jin C; Fu DL Discov Med; 2016 Sep; 22(120):121-128. PubMed ID: 27755967 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer: Are "liquid biopsies" ready for prime-time? Lewis AR; Valle JW; McNamara MG World J Gastroenterol; 2016 Aug; 22(32):7175-85. PubMed ID: 27621566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]